AlloSure
Commercial- Indications
- Organ transplant rejection monitoring
Company intelligence / Profile preview
CareDx
South San Francisco, California, USAcaredx.com ↗
- Ownership
- Public · CDNA
- Employees
- ~650
- Development stage
- Commercial
01
Overview
CareDx’s non-invasive genomic tests such as AlloMap and AlloSure are widely adopted in U.S. transplant centers for post-transplant surveillance. Over 100 peer-reviewed publications support their clinical utility in kidney and heart transplantation. More than 100,000 patients have benefited from these services to date
- Therapeutic areas
- OncologyImmunology
- Modalities
- Diagnostic testGenomics-based diagnosticsNext-generation sequencing (NGS) assay
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Veracyte (transplant rejection testing on nCounter system)IDbyDNAWeill Cornell Medicinemultiple biopharma partners using AlloCell for CAR-T studies
04
Financials
- Market cap
- $2.6B
- Total revenue
- $131.9M
- Enterprise value
- $2.2B
Beyond the preview
Go deeper on CareDx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CareDx.